paroxetine has been researched along with 5,7-dihydroxytryptamine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (78.95) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culp, S; DeSouza, EB; Lehmann, J; Zaczek, R | 1 |
| Martens, JM; Pranzatelli, MR | 1 |
| Dodds, SM; Marshall, EF; Milne, J | 1 |
| Hill, DR; Stoessl, AJ | 1 |
| Briley, M; Moret, C | 1 |
| Ricaurte, GA; Scheffel, U | 1 |
| Briley, M; Chopin, P; Moret, C | 1 |
| Barone, P; Briley, M; Fillion, G; Moret, C | 1 |
| Gobbi, M; Mennini, T; Palacios, JM; Pompeiano, M; Regondi, MC | 1 |
| Frankfurt, M; McEwen, BS; McKittrick, CR; Mendelson, SD | 2 |
| Pranzatelli, MR | 1 |
| Kitatani, T; Shibuya, T; Watanabe, Y | 1 |
| Mahatme, A; Rowland, NE; Semple-Rowland, SL | 1 |
| Lima, L; Urbina, M | 1 |
| Béïque, JC; Blier, P; de Montigny, C; Debonnel, G | 1 |
| Blier, P; Szabo, ST | 1 |
| Haneda, E; Higuchi, M; Kobayashi, K; Suhara, T; Suzuki, H | 1 |
| Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ | 1 |
19 other study(ies) available for paroxetine and 5,7-dihydroxytryptamine
| Article | Year |
|---|---|
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atrophy; Brain; Cerebral Ventricles; Designer Drugs; Dopamine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Organ Specificity; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1992 |
Plasticity and ontogeny of the central 5-HT transporter: effect of neonatal 5,7-dihydroxytryptamine lesions in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Binding Sites; Brain Stem; Cerebral Cortex; Dose-Response Relationship, Drug; Injections, Intraventricular; Neuronal Plasticity; Paroxetine; Rats; Serotonin; Spinal Cord | 1992 |
Effects of paroxetine on 5-HT-induced head twitches and phosphatidylinositol hydrolysis in mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Cerebral Cortex; Hydrolysis; Mice; Mice, Inbred BALB C; Paroxetine; Phosphatidylinositols; Serotonin; Spinal Cord | 1992 |
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Brain; Kinetics; Male; Organ Specificity; Paroxetine; Peptide Fragments; Piperidines; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Reference Values; Serotonin Antagonists; Substance P; Tachykinins; Tritium | 1990 |
Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Depressive Disorder; Imipramine; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists | 1991 |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Ligands; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Synapses; Tomography, Emission-Computed; Tritium | 1990 |
Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Anxiety; Behavior, Animal; Brain Chemistry; Injections, Intraventricular; Kinetics; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Autoradiographic characterization of binding sites for [3H]milnacipran, a new antidepressant drug, and their relationship to the serotonin transporter in rat brain.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Benzylamines; Binding Sites; Binding, Competitive; Biological Transport; Brain; Brain Chemistry; Cyclopropanes; Milnacipran; Paroxetine; Rats; Rats, Wistar; Serotonin Receptor Agonists; Tritium | 1994 |
Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration of 5-HT1A receptors and 5-HT uptake sites in the rat brain.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Brain; Citalopram; Male; Nerve Degeneration; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Serotonin | 1994 |
Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Brain Chemistry; Carrier Proteins; Estrogens; Female; Gonadal Steroid Hormones; Hippocampus; Iodocyanopindolol; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Orchiectomy; Ovariectomy; Paroxetine; Pindolol; Progesterone; Rats; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins; Ventromedial Hypothalamic Nucleus | 1994 |
Dissociation of the plasticity of 5-HT1A sites and 5-HT transporter sites.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Animals, Newborn; Brain; Carrier Proteins; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organ Specificity; Paroxetine; Rats; Receptors, Serotonin; Reference Values; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spinal Cord; Tritium | 1994 |
Alterations of serotonin receptor binding in the hypothalamus following acute denervation.
Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Denervation; Dorsomedial Hypothalamic Nucleus; Hippocampus; Hypothalamic Area, Lateral; Hypothalamus; Injections; Ligands; Male; Paroxetine; Rats; Receptors, Serotonin; Ventromedial Hypothalamic Nucleus | 1993 |
Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Brain; Fenclonine; Male; Mice; Mice, Inbred ICR; Neurons; Paroxetine; Serotonin; Xanthines | 1993 |
Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe.
Topics: 5,7-Dihydroxytryptamine; Animals; Carrier Proteins; Enzyme Induction; Fenfluramine; Gene Expression Regulation; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Polymerase Chain Reaction; Raphe Nuclei; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase | 1996 |
Serotonergic projections to the retina of rat and goldfish.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Cell Membrane; Goldfish; Hydroxyindoleacetic Acid; Kinetics; Male; Neural Pathways; Optic Nerve; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Retina; Serotonin; Serotonin Agents; Superior Colliculi; Tritium | 1998 |
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Topics: 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Cyclohexanols; Drug Synergism; Electrophysiology; Extracellular Space; Hippocampus; Injections, Intravenous; Male; Paroxetine; Pindolol; Piperazines; Pyramidal Cells; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Electric Stimulation; Electrophysiology; Fluorobenzenes; Idazoxan; Locus Coeruleus; Male; Neurons; Norepinephrine; Paroxetine; Patch-Clamp Techniques; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2001 |
Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Benzazepines; Biophysics; Dopamine Antagonists; Electric Stimulation; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mossy Fibers, Hippocampal; Paroxetine; Patch-Clamp Techniques; Protein Binding; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin Agents; Tritium; Up-Regulation | 2012 |
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Disease Models, Animal; Hippocampus; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome | 2014 |